ArticleCancer chemotherapy and pharmacology2016

Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphoma.

Jamie E Flerlage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.